CD8A and neoplasm: Pathological responses were seen in 70% of patients, with 50% having a complete pathological response (pCR), and was associated with increased CD8 + tumor-infiltrating lymphocytes (TILs) and intratumoral CD303 + plasmacytoid dendritic cells (DCs).